🇪🇺 Biktarvy in European Union

EMA authorised Biktarvy on 21 June 2018

Marketing authorisation

EMA — authorised 21 June 2018

  • Marketing authorisation holder: Gilead Sciences International Limited
  • Status: approved

Biktarvy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Biktarvy approved in European Union?

Yes. EMA authorised it on 21 June 2018.

Who is the marketing authorisation holder for Biktarvy in European Union?

Gilead Sciences International Limited holds the EU marketing authorisation.